UC Professor Named to Prostate Cancer Conference Committee
CINCINNATIShuk-mei Ho, PhD, chair of the University of Cincinnatis (UC) environmental health department, has been appointed to the technical planning committee for the 2007 research conference of the U.S. Department of Defense Prostate Cancer Research Program (PCRP).
The inaugural conferenceknown as IMPaCT: Innovative Minds in Prostate Cancer Todaywill bring together about 1,000 leading scientists and prostate cancer advocates from across the world to exchange ideas and explore new avenues that have potential to advance prostate cancer research.
The conference will take place in September 2007 during prostate cancer awareness month. A location is yet to be determined.
As a member of the 19-person committee, Ho will help design and implement all aspects of the conference, including selecting speakers and developing individual group sessions and educational workshops.
"The PCRP has had great success funding high-impact research that addresses health disparities and trains the next generation of prostate cancer researchers, say Ho. "Im thrilled to be part of the team.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.